See the PhD Opportunities section to see if this project is currently open for applications via MIBTP.
Please Note: The main page lists projects via BBSRC Research Theme(s) quoted and then relevant Topic(s).
Biological understanding of injectable fluid gel formulations
Secondary Supervisor(s): Dr Rowan Hardy
University of Registration: University of Birmingham
BBSRC Research Themes:
Project Outline
Due to their biocompatibility, biodegradability, and tuneable mechanical properties, hydrogels are widely employed in Regenerative Medicine. Hydrogels are excellent extracellular matrix mimetics and are commonly used for the controlled delivery of bioactives/cells. However, hydrogels are structured (gelled) prior to use and thus require surgery for implantation, which can result in tissue damage and increased therapeutic costs.
These issues have led to interest in minimally invasive implantation strategies, such as the injectable hydrogel approach. Yet, although injectable hydrogels provide treatment without surgery, they suffer from inconsistent/unpredictable therapeutic action as they rely on gelation in situ (in the body), which is challenging due to the presence of interfering endogenous species (ions, proteins).
Fluid gels (FGs) have emerged as promising candidates for use as injectable hydrogels. FGs possess a highly viscoelastic microstructure and the capacity to self-structure at rest, both of which have generated interest in the use of FGs as a dynamic hydrogel scaffold; one that is prepared (gelled) exogenously and then injected (flows under shear) into the body, forming robust structures once in place (at rest). The benefit of using FGs arises from the fact that these constructs are already gelled and thus intrusion from ‘local’ species in the body should be minimal.
Bringing together expertise from the biomedical and physical sciences, the current project aims to evaluate the use of FGs as injectable hydrogels and understand their behaviour in the body. Using a combination of rheological and cell culture approaches, we will investigate FG injectability, lubrication, drug retention/release and physiological pathways and biocompatibility. This interdisciplinary project will be supervised by Dr Fotis Spyropoulos, an expert in the production, characterisation and performance of FGs and Dr Rowan Hardy, a leader in steroid metabolism and signalling.